Abstract:To analyze the direct economic impact of two postoperative vaginal-cuff brachytherapy (VBT) schedules in endometrial carcinoma (EC) with similar vaginal control and toxicity results. Hypothesis: A lesser number of fractions should allow savings in VBT. From 2006-2015, 397 postoperative EC patients were treated with VBT with a mean of 40 patients/year; 70% of patients received EBI+VBT and the 30% exclusive VBT. Schedule 1: 3 fractions after external beam irradiation (EBI) and 6 fractions in exclusive BT (4-6Gy per fraction); Schedule 2: 1 fraction of 7Gy after EBI and 3 fractions of 6Gy exclusive BT. The differential cost analysis between the 2 schedules were performed retrospectively. The following were considered as a direct cost in each schedule: 1) Personnel costs (technicians in radiotherapy, nurses, medical physicists, administrative personnel, orderlies); the time dedicated by each professional during: CT Planning acquisitions and vagina and OAR delineation, dosimetric study, dosimetry evaluation, auto-radiography, procedure reporting time during and after treatment, removal of bladder and rectal tubes, removal and cleaning of applicators, sterilization procedures and transportation of material for sterilization; 2) Health care material (gels, gauzes, among others); 3) Imputation of treatment equipment costs (length of time of equipment use). The differential between the two schedules was estimated. A limitation of the study was that indirect costs and evaluation of quality of life adjusted costs were not considered in the present analysis. In schedule 2 the savings in treatment time per year was of 4.185 minutes (70 hours).The estimated savings in personnel was of 290€ per patient while that of sanitary material and equipment was of 23€ per patient treated. The overall savings per patient was 313€. Thus, the total savings per year with the use of schedule 2 in 40 patients was of 12,520€. A reduction of one third in the number of fractions in VBT of postoperative EC allowed an economic savings per patient of 313€ or 12520€ per year (40 patients). Other possible benefits of a reduction in the number of fractions include patient comfort and fewer treatment visits allowing investment in other patient benefits. Grant: Spanish Association against Cancer (AECC) Foundation.

Economic Impact Of Decreasing The Number Of Fractions In Postoperative Brachytherapy Of Endometrial Carcinoma By One Third.